Skip to main content
. 2022 Oct 13;12:17151. doi: 10.1038/s41598-022-22090-7

Table 2.

The relationship between antiplatelet agent use and 5-year rate of ischemic stroke recurrence among patients with first-time hemorrhage stroke (n = 7589).

Variables Number Number of IS event Person-years Incidence rate per 100 person-years Crude HR (95% CI) Adjusted HR (95% CI)
Age
20–44 970 22 4259.6 0.52 Ref Ref
45–59 2704 157 11,294.0 1.39 2.68 (1.71–4.18) 2.17 (1.38–3.41)
 ≥ 60 3915 286 13,318.7 2.15 4.05 (2.62–6.24) 2.99 (1.91–4.68)
Sex
Female 2978 171 11,381.1 1.50 Ref Ref
Male 4611 294 17,491.3 1.68 1.12 (0.93–1.35) 1.23 (1.02–1.49)
Length of stay, days
 < 9 1831 140 7485.4 1.87 Ref Ref
 ≥ 9 5758 325 21,386.9 1.52 0.81 (0.66–0.99) 0.90 (0.73–1.11)
ICU
No 6036 399 23,614.7 1.69 Ref Ref
Yes 1553 66 5257.6 1.26 0.74 (0.57–0.96) 0.86 (0.76–0.97)
CCI
 < 5 5029 295 20,121.6 1.47 Ref Ref
 ≥ 5 2560 170 8750.7 1.94 1.29 (1.07–1.56) 0.87 (0.70–1.08)
Antiplatelet agents
No 5529 306 19,990.5 1.53 Ref Ref
Yes 2060 159 8881.8 1.79 1.18 (0.97–1.43) 0.90 (0.74–1.09)
Diabetes mellitus
No 5251 286 20,459.9 1.40 Ref Ref
Yes 2338 179 8412.4 2.13 1.50 (1.25–1.81) 1.28 (1.04–1.57)
Hypertension
No 842 14 3237.6 0.43 Ref Ref
Yes 6747 451 25,634.7 1.76 4.02 (2.36–6.84) 2.68 (1.55–4.63)
Hyperlipidemia
No 5250 287 19,453.8 1.48 Ref Ref
Yes 2339 178 9418.5 1.89 1.29 (1.07–1.55) 1.11 (0.92–1.35)
AF
No 7269 425 27,910.2 1.52 Ref Ref
Yes 320 40 962.1 4.16 2.64 (1.91–3.65) 1.97 (1.40–2.76)
CVD
No 5587 291 21,742.8 1.34 Ref Ref
Yes 2002 174 7129.5 2.44 1.80 (1.49–2.17) 1.42 (1.15–1.74)
CHF
No 4164 220 16,216.6 1.36 Ref Ref
Yes 3425 245 12,655.8 1.94 1.41 (1.18–1.69) 0.98 (0.81–1.20)
The history of IS
No 7272 429 27,966.0 1.53 Ref Ref
Yes 317 36 906.3 3.97 2.51 (1.79–3.53) 1.69 (1.18–2.40)

ICU, intensive care unit; CI, confidence interval; AF, atrial fibrillation; CHF, congestive heart failure; IS, ischemic stroke; HR, hazard ratio; CVD, cardiovascular disease.